Crossmark

Curcumin and Epigallocatechin-3-Gallate: Targeting Receptor Tyrosine Kinases and their Signaling Pathways in Cancer Therapy

Crossref DOI link: https://doi.org/10.1007/s40495-024-00379-7

Published Online: 2024-10-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghobadi, Niloofar

Asoodeh, Ahmad https://orcid.org/0000-0002-1406-0595
License Information

Text and Data Mining valid from 2024-10-08

Version of Record valid from 2024-10-08
More Information

Article History

Accepted: 17 September 2024

First Online: 8 October 2024

Declaration

:

: The authors have no conflict of interest to disclose.